Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
71,858,757
-
Total 13F shares
-
6,591,632
-
Share change
-
+37,200
-
Total reported value
-
$41,683,415
-
Price per share
-
$6.47
-
Number of holders
-
14
-
Value change
-
-$241,827
-
Number of buys
-
2
-
Number of sells
-
2
Institutional Holders of SINOVAC BIOTECH LTD. - Common Shares (SVA) as of Q3 2023
As of 30 Sep 2023,
SINOVAC BIOTECH LTD. - Common Shares (SVA) was held by
14 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,591,632 shares.
The largest 10 holders included
Vivo Capital, LLC, Neumann Advisory Hong Kong Ltd, STATE STREET CORP, Yorktown Management & Research Co Inc, GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, UBS Group AG, MORGAN STANLEY, JPMORGAN CHASE & CO, and WELLS FARGO & COMPANY/MN.
This page lists
14
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.